CTRI/2022/11/047335尚未招募未知
Evaluation of irritation potential of Makeup Care Formulations on healthy human subjects
TTK Healthcare limited Consumer product division0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Healthy Human Subjects
- •2) Skin should be healthy on the
- •studied anatomic unit (free of eczema, wounds, inflammatory
- •3) Subjects willing to come for regular follow up and
- •ready to follow instructions during the study period.
- •4) Subjects
- •representing varied skin types (ideally equal representation of all 4
- •skin types â?? Oily, Normal, Dry and Combination)
排除标准
- •1 For female: Being pregnant or breastfeeding or having stopped to
- •breastfeed in the past three months
- •2 Having refused to give his/her assent by not signing the consent
- •3 Taking part in another study liable to interfere with this study
- •4 Being diabetic.
- •5 Being asthmatic.
- •6 Following a chronic medicinal treatment comprising any of the
- •following products: aspirin-based products, anti-inflammatories,
- •antihistamines, corticotherapy, taken by general or local routes (the
- •only medication permitted is paracetamol).
- •7 Having cutaneous hypersensitivity (except in the case of studies
- •with evaluation of sensitive skin).
- •8 Having a diagnosed or highly probable allergy to one or several
- •compounds of the cosmetic products.
- •9 Having undergone a surgery requiring a general anaesthesia of
- •more than one hour in the past 6 months.
- •10 Having changed his/her cosmetic habits in the 14 days preceding
- •the start of the study on the studied anatomic unit.
- •11 The day of the patch application: no cosmetic product must be
- •used (test site clean with water only). Refusing to follow the
- •restrictions below during the study: - For female: Do not become
- •pregnant nor breastfeed. - Do not take part in another study liable to
- •interfere with this study - Do not take medicinal treatment comprising
- •any of the following products: aspirin-based products,
- •anti-inflammatories, and antihistamines, corticotherapy, taken by
- •general or local routes (the only medication permitted is
- •paracetamol). - Do not change his/her cosmetic habits apart from the
- •particular conditions mentioned in the protocol, on the studied
- •anatomic unit
- •12 Having eczema, psoriasis, lichen plan, vitiligo whatever the
- •considered area
- •13 Having disorder of the healing (whatever the considered area) •
- •Having a rhinitis, allergic conjunctivitis, or rhino sinusitis
- •14 Having an allergy to perfumes and/or conservatives in cosmetic
- •15 Having an allergy to plaster
- •16 Having a food allergy
- •17 Having a cardiovascular pathology (taking a beta blocker
- •18 Having immunosuppressive drugs, such as cyclophosphamide,
- •methotrexate, azathioprine, etc.
- •19 Taking a retinoid-based treatment by general or oral route
- •20 Taking specific treatment on the back.
- •21 Having taken an anti-histaminic treatment in the last 2 weeks
- •preceding the start of the study
- •22 Having miliaria (prickly heat) on the back.
- •23 Presenting too many naevus on the back
- •24 Having high pilosity on the back.
- •25 Refusing to follow the restrictions below during the study: - During
- •the first 24 hours (after patch application), neither cosmetic products
- •nor water must be applied on the back. - Till the follow up period of
- •until T8 days, only water is accepted from the first reading i.e., T2
- 另有 3 项未显示
研究者
相似试验
尚未招募
Unknown
Safety check of makeup productsCTRI/2024/06/068450House of Beauty private Ltd.
已完成
不适用
Safety assessment of makeup ProductsCTRI/2023/01/049242TTK Healthcare limited Consumer product division26
已完成
Unknown
Safety evaluation of Skin care formulationsCTRI/2023/05/053027Mosaic wellness pvt ltd25
尚未招募
Unknown
Safety check of test productCTRI/2023/10/059132PIGEON INDIA PRIVATE LIMITED
尚未招募
1 期
Safety check of products on human volunteersCTRI/2024/08/071858aturoshift